These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2274676)

  • 41. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
    Niederau C; Faber S; Karaus M
    Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of loxiglumide on gallbladder emptying in healthy volunteers.
    Niederau C; Heintges T; Rovati L; Strohmeyer G
    Gastroenterology; 1989 Nov; 97(5):1331-6. PubMed ID: 2792664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effect of intraduodenal infusion of loxiglumide on pancreatic exocrine secretion.
    Tanikawa M; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Kodaira T; Hamaoka T
    Arzneimittelforschung; 1993 Jan; 43(1):35-9. PubMed ID: 8447844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cephalic stimulation of gastrointestinal secretory and motor responses in humans.
    Katschinski M; Dahmen G; Reinshagen M; Beglinger C; Koop H; Nustede R; Adler G
    Gastroenterology; 1992 Aug; 103(2):383-91. PubMed ID: 1634057
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans.
    Konturek SJ; Kwiecien N; Obtulowicz W; Kopp B; Oleksy J; Rovati L
    Digestion; 1990; 45(1):1-8. PubMed ID: 2340960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
    Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
    Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of CCK on pancreatic function and morphology.
    Niederau C; Lüthen R; Heintges T
    Ann N Y Acad Sci; 1994 Mar; 713():180-98. PubMed ID: 8185159
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation.
    Höcker M; Schmidt WE; Creutzfeldt W; Choudhury AR; Nustede R; Schafmayer A; Fölsch UR
    Regul Pept; 1992 Feb; 37(3):255-69. PubMed ID: 1557514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of cholecystokinin in the intestinal phase of pancreatic circulation in dogs.
    Nakajima M; Naruse S; Kitagawa M; Ishiguro H; Jin C; Ito O; Hayakawa T
    Am J Physiol Gastrointest Liver Physiol; 2001 Apr; 280(4):G614-20. PubMed ID: 11254487
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the specific cholecystokinin-receptor antagonist loxiglumide on bombesin stimulated pancreatic enzyme secretion in man.
    Jebbink MC; Jansen JB; Mooy DM; Rovati LC; Lamers CB
    Regul Pept; 1991 Feb; 32(3):361-8. PubMed ID: 1714084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of cholecystokinin in regulation of gastrointestinal motor functions.
    Meyer BM; Werth BA; Beglinger C; Hildebrand P; Jansen JB; Zach D; Rovati LC; Stalder GA
    Lancet; 1989 Jul; 2(8653):12-5. PubMed ID: 2567793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of effect of the specific cholecystokinin receptor antagonist loxiglumide on cholecystokinin clearance from plasma in man.
    Jebbink MC; Jansen JB; Masclee AA; Lamers CB
    Br J Clin Pharmacol; 1990 Jun; 29(6):770-3. PubMed ID: 2378793
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intraduodenal fat.
    Brzozowski T; Konturek PC; Konturek SJ; Kwiecién S; Pajdo R; Brzozowska I; Hahn EG
    J Clin Gastroenterol; 1998; 27 Suppl 1():S125-37. PubMed ID: 9872509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans.
    Verhulst ML; Gielkens HA; Hopman WP; van Schaik A; Tangerman A; Rovati LC; Jansen JB
    Regul Pept; 1994 Oct; 53(3):185-93. PubMed ID: 7846294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs.
    Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV
    Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of loxiglumide (CR-1505) on bombesin- and meal-stimulated plasma cholecystokinin in man.
    Jansen JB; Jebbink MC; Douglas BR; Lamers CB
    Eur J Clin Pharmacol; 1990; 38(4):367-70. PubMed ID: 2344859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the cholecystokinin-receptor antagonist lorglumide on pancreatic enzyme secretion stimulated by bombesin, food, and caerulein, giving similar plasma cholecystokinin concentrations in the dog.
    de Jong AJ; Singer MV; Jansen JB; Niebel W; Rovati LC; Lamers CB
    Gut; 1991 Feb; 32(2):215-9. PubMed ID: 1864545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholecystokinin is a physiological regulator of gastric acid secretion in man.
    Burckhardt B; Delco F; Ensinck JW; Meier R; Bauerfeind P; Aufderhaar U; Ketterer S; Gyr K; Beglinger C
    Eur J Clin Invest; 1994 Jun; 24(6):370-6. PubMed ID: 7957488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.